During the past decade, Alabama Oncology St. Vincent's Birmingham conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Alabama Oncology St. Vincent's Birmingham" are "Hematologic Malignancies" (2 trials), "Solid Tumor" (2 trials), "Carcinoma, Non-squamous Non-small-cell Lung" (1 trials), "Carcinoma, Squamous Cell, Non-small-cell Lung" (1 trials) and "Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Alabama Oncology St. Vincent's Birmingham" in a lesser frequency.

Most popular intervention types in "Alabama Oncology St. Vincent's Birmingham" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Olaparib" (2 trials), "Pembrolizumab" (2 trials), "Placebo" (2 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alabama Oncology St. Vincent's Birmingham" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Alabama Oncology St. Vincent's Birmingham". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Alabama Oncology St. Vincent's Birmingham, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Alabama Oncology St. Vincent's Birmingham, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".